
Global Medical REIT (GMRE) | Financial Analysis & Statements
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Jun 2025Income Metrics
Revenue
37.9M
Gross Profit
29.7M
78.31%
Operating Income
8.3M
22.04%
Net Income
585.0K
1.54%
EPS (Diluted)
$-0.01
Balance Sheet Metrics
Total Assets
1.3B
Total Liabilities
731.5M
Shareholders Equity
538.1M
Debt to Equity
1.36
Cash Flow Metrics
Operating Cash Flow
13.5M
Free Cash Flow
-22.3M
Revenue & Profitability Trend
Global Medical REIT Income Statement From 2020 to 2024
Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|---|
Revenue | 138.4M | 140.9M | 137.2M | 115.8M | 93.5M |
Cost of Goods Sold | 29.3M | 28.1M | 25.2M | 15.5M | 10.9M |
Gross Profit | 109.2M | 112.9M | 112.0M | 100.3M | 82.7M |
Gross Margin % | 78.9% | 80.1% | 81.6% | 86.6% | 88.4% |
Operating Expenses | |||||
Research & Development | - | - | - | - | - |
Selling, General & Administrative | 21.1M | 16.9M | 16.5M | 16.5M | 30.0M |
Other Operating Expenses | - | - | - | - | - |
Total Operating Expenses | 21.1M | 16.9M | 16.5M | 16.5M | 30.0M |
Operating Income | 32.7M | 37.9M | 38.7M | 37.0M | 16.3M |
Operating Margin % | 23.6% | 26.9% | 28.2% | 31.9% | 17.5% |
Non-Operating Items | |||||
Interest Income | - | - | - | - | - |
Interest Expense | 28.7M | 30.9M | 25.2M | 19.7M | 18.7M |
Other Non-Operating Income | 2.7M | 14.8M | 6.5M | 1.0M | -153.0K |
Pre-tax Income | 6.7M | 21.7M | 20.0M | 18.3M | -2.5M |
Income Tax | - | - | - | - | - |
Effective Tax Rate % | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
Net Income | 6.7M | 21.7M | 20.0M | 18.3M | -2.5M |
Net Margin % | 4.8% | 15.4% | 14.6% | 15.8% | -2.7% |
Key Metrics | |||||
EBITDA | 89.1M | 97.0M | 96.5M | 84.4M | 53.4M |
EPS (Basic) | $0.01 | $0.23 | $0.20 | $0.19 | $-0.17 |
EPS (Diluted) | $0.01 | $0.23 | $0.20 | $0.19 | $-0.17 |
Basic Shares Outstanding | 65936000 | 65550000 | 65462000 | 60640000 | 46256000 |
Diluted Shares Outstanding | 65936000 | 65550000 | 65462000 | 60640000 | 46256000 |
Income Statement Trend
Global Medical REIT Balance Sheet From 2020 to 2024
Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|---|
Assets | |||||
Current Assets | |||||
Cash & Equivalents | 6.8M | 1.3M | 4.0M | 7.2M | 5.5M |
Short-term Investments | - | - | - | - | - |
Accounts Receivable | 7.4M | 6.8M | 8.0M | 6.1M | 5.6M |
Inventory | - | - | - | - | - |
Other Current Assets | - | - | - | - | - |
Total Current Assets | 17.3M | 14.4M | 30.5M | 24.9M | 21.3M |
Non-Current Assets | |||||
Property, Plant & Equipment | 7.3M | 7.6M | 3.5M | 3.8M | 3.6M |
Goodwill | 65.9M | 77.8M | 103.1M | 99.7M | 85.5M |
Intangible Assets | 54.1M | 66.0M | 91.3M | 87.9M | 73.7M |
Long-term Investments | 18.6M | 25.1M | 34.7M | 1.2M | 0 |
Other Non-Current Assets | 34.7M | 30.0M | 31.2M | 25.7M | 20.8M |
Total Non-Current Assets | 1.2B | 1.3B | 1.4B | 1.2B | 1.1B |
Total Assets | 1.3B | 1.3B | 1.4B | 1.3B | 1.1B |
Liabilities | |||||
Current Liabilities | |||||
Accounts Payable | 16.5M | 12.8M | 13.8M | 10.3M | 7.3M |
Short-term Debt | 631.7M | 585.3M | 636.4M | 514.6M | 521.6M |
Current Portion of Long-term Debt | - | - | - | - | - |
Other Current Liabilities | - | - | - | - | - |
Total Current Liabilities | 671.4M | 619.3M | 670.5M | 540.6M | 541.4M |
Non-Current Liabilities | |||||
Long-term Debt | 25.8M | 33.6M | 60.6M | 57.2M | 64.9M |
Deferred Tax Liabilities | - | - | - | - | - |
Other Non-Current Liabilities | 3.3M | 9.0M | 13.1M | 20.4M | 18.7M |
Total Non-Current Liabilities | 29.1M | 42.5M | 73.7M | 85.3M | 101.8M |
Total Liabilities | 700.6M | 661.9M | 744.2M | 625.9M | 643.1M |
Equity | |||||
Common Stock | 67.0K | 66.0K | 66.0K | 65.0K | 49.0K |
Retained Earnings | -293.7M | -239.0M | -198.7M | -157.0M | -116.8M |
Treasury Stock | - | - | - | - | - |
Other Equity | - | - | - | - | - |
Total Shareholders Equity | 555.9M | 605.8M | 649.1M | 637.6M | 457.8M |
Key Metrics | |||||
Total Debt | 657.5M | 618.9M | 697.0M | 571.7M | 586.6M |
Working Capital | -654.1M | -605.0M | -640.0M | -515.6M | -520.1M |
Balance Sheet Composition
Global Medical REIT Cash Flow Statement From 2020 to 2024
Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|---|
Operating Activities | |||||
Net Income | 6.7M | 21.7M | 20.0M | 18.3M | -2.5M |
Depreciation & Amortization | 56.1M | 59.0M | 57.7M | 47.3M | 36.8M |
Stock-Based Compensation | 5.1M | 4.2M | 4.7M | 5.8M | 5.3M |
Working Capital Changes | -1.4M | -3.9M | -2.7M | -4.0M | -6.0M |
Operating Cash Flow | 69.1M | 84.1M | 82.4M | 69.7M | 35.2M |
Investing Activities | |||||
Capital Expenditures | -81.7M | -442.0K | -150.9M | -192.3M | -217.7M |
Acquisitions | -2.1M | - | 0 | 0 | -5.1M |
Investment Purchases | - | - | - | - | - |
Investment Sales | - | - | - | - | - |
Investing Cash Flow | -89.9M | -1.7M | -149.9M | -190.7M | -222.6M |
Financing Activities | |||||
Share Repurchases | - | - | - | - | 0 |
Dividends Paid | -65.7M | -64.8M | -64.2M | -58.3M | -45.8M |
Debt Issuance | 143.8M | - | 0 | 221.6M | 253.2M |
Debt Repayment | -111.1M | -169.2M | -16.7M | -232.2M | -65.0M |
Financing Cash Flow | -21.9M | -280.2M | 46.9M | 125.1M | 366.6M |
Free Cash Flow | -25.1M | 58.4M | -79.7M | -132.7M | -184.3M |
Net Change in Cash | -42.7M | -197.8M | -20.6M | 4.0M | 179.2M |
Cash Flow Trend
Global Medical REIT Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
95.29
Forward P/E
83.38
Price to Book
1.04
Price to Sales
6.39
PEG Ratio
-1.19
Profitability Ratios
Profit Margin
7.25%
Operating Margin
23.61%
Return on Equity
1.93%
Return on Assets
1.67%
Financial Health
Current Ratio
1.32
Debt to Equity
138.39
Beta
1.19
Per Share Data
EPS (TTM)
$0.07
Book Value per Share
$6.40
Revenue per Share
$2.13
Peer Financial Comparison
Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
---|---|---|---|---|---|---|
gmre | 907.1M | 95.29 | 1.04 | 1.93% | 7.25% | 138.39 |
Welltower | 109.0B | 91.01 | 3.02 | 3.45% | 12.18% | 47.36 |
Ventas | 28.9B | 194.30 | 2.52 | 1.38% | 2.82% | 108.90 |
LTC Properties | 1.7B | 19.85 | 1.73 | 8.80% | 39.03% | 66.65 |
Sila Realty Trust | 1.4B | 34.66 | 0.99 | 2.79% | 20.85% | 45.94 |
Diversified | 816.0M | -2.25 | 0.44 | -14.32% | -18.83% | 143.14 |
Financial data is updated regularly. All figures are in the company's reporting currency.